Copyright Reports & Markets. All rights reserved.

Global High Affinity Nerve Growth Factor Receptor Sales Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Global High Affinity Nerve Growth Factor Receptor Sales Market Report 2019

      1 High Affinity Nerve Growth Factor Receptor Market Overview

      • 1.1 High Affinity Nerve Growth Factor ReceptorProduct Overview
      • 1.2 High Affinity Nerve Growth Factor Receptor Segment by Type
        • 1.2.1 Global High Affinity Nerve Growth Factor Receptor Sales Comparison by Types (2014-2025)
        • 1.2.2 ASP-7962
        • 1.2.3 AZD-7451
        • 1.2.4 BNN-27
        • 1.2.5 Cenegermin
        • 1.2.6 CRB-0089
        • 1.2.7 Others
      • 1.3 High Affinity Nerve Growth Factor Receptor Segment by Application
        • 1.3.1 Global High Affinity Nerve Growth Factor Receptor Sales Comparison by Application (2014-2025)
        • 1.3.1 Bile Duct Cancer
        • 1.3.2 Papillary Thyroid Cancer
        • 1.3.3 Low Back Pain
        • 1.3.4 Lung Cancer
        • 1.3.5 Others
      • 1.4 High Affinity Nerve Growth Factor Receptor Market by Region
        • 1.4.1 Global High Affinity Nerve Growth Factor Receptor Revenue Comparison by Region (2014-2025)
        • 1.4.2 United States High Affinity Nerve Growth Factor Receptor Status and Prospect (2014-2025)
        • 1.4.3 Europe High Affinity Nerve Growth Factor Receptor Status and Prospect (2014-2025)
        • 1.4.4 China High Affinity Nerve Growth Factor Receptor Status and Prospect (2014-2025)
        • 1.4.5 Japan High Affinity Nerve Growth Factor Receptor Status and Prospect (2014-2025)
        • 1.4.6 Southeast Asia High Affinity Nerve Growth Factor Receptor Status and Prospect (2014-2025)
        • 1.4.7 India High Affinity Nerve Growth Factor Receptor Status and Prospect (2014-2025)
      • 1.5 Global High Affinity Nerve Growth Factor Receptor Sales and Revenue (2014-2025)
        • 1.5.1 Global High Affinity Nerve Growth Factor Receptor Sales and Growth Rate (2014-2025)
        • 1.5.2 Global High Affinity Nerve Growth Factor Receptor Revenue and Growth Rate (2014-2025)

      2 High Affinity Nerve Growth Factor Receptor by Company, Region, Type and Application

      • 2.1 Global High Affinity Nerve Growth Factor Receptor Market Competition by Companies
        • 2.1.1 Global High Affinity Nerve Growth Factor Receptor Sales Market Share of Key Companies (2014-2019)
        • 2.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Company (2014-2019)
      • 2.2 Global High Affinity Nerve Growth Factor Receptor Sales and Revenue by Region
        • 2.2.1 Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Region (2014-2019)
        • 2.2.2 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Region (2014-2019)
      • 2.3 Global High Affinity Nerve Growth Factor Receptor Sales and Revenue by Type
        • 2.3.1 Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Type (2014-2019)
        • 2.3.2 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2014-2019)
      • 2.4 Global High Affinity Nerve Growth Factor Receptor Sales by Application

      3 United States High Affinity Nerve Growth Factor Receptor Sales, Revenue and Price

      • 3.1 United States High Affinity Nerve Growth Factor Receptor Sales and Revenue (2014-2019)
        • 3.1.1 United States High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2014-2019)
        • 3.1.2 United States High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2014-2019)
        • 3.1.3 United States High Affinity Nerve Growth Factor Receptor Price Trend (2014-2019)
      • 3.2 United States High Affinity Nerve Growth Factor Receptor Sales Market Share by Company
      • 3.3 United States High Affinity Nerve Growth Factor Receptor Sales Market Share by Type
      • 3.4 United States High Affinity Nerve Growth Factor Receptor Sales Market Share by Application

      4 Europe High Affinity Nerve Growth Factor Receptor Sales, Revenue and Price

      • 4.1 Europe High Affinity Nerve Growth Factor Receptor Sales and Value (2014-2019)
        • 4.1.1 Europe High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2014-2019)
        • 4.1.2 Europe High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2014-2019)
        • 4.1.3 Europe High Affinity Nerve Growth Factor Receptor Price Trend (2014-2019)
      • 4.2 Europe High Affinity Nerve Growth Factor Receptor Sales Market Share by Company
      • 4.3 Europe High Affinity Nerve Growth Factor Receptor Sales Market Share by Type
      • 4.4 Europe High Affinity Nerve Growth Factor Receptor Sales Market Share by Application

      5 China High Affinity Nerve Growth Factor Receptor Sales, Revenue and Price

      • 5.1 China High Affinity Nerve Growth Factor Receptor Sales and Revenue (2014-2019)
        • 5.1.1 China High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2014-2019)
        • 5.1.2 China High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2014-2019)
        • 5.1.3 China High Affinity Nerve Growth Factor Receptor Price Trend (2014-2019)
      • 5.2 China High Affinity Nerve Growth Factor Receptor Sales Market Share by Company
      • 5.3 China High Affinity Nerve Growth Factor Receptor Sales Market Share by Type
      • 5.4 China High Affinity Nerve Growth Factor Receptor Sales Market Share by Application

      6 Japan High Affinity Nerve Growth Factor Receptor Sales, Revenue and Price

      • 6.1 Japan High Affinity Nerve Growth Factor Receptor Sales and Value (2014-2019)
        • 6.1.1 Japan High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2014-2019)
        • 6.1.2 Japan High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2014-2019)
        • 6.1.3 Japan High Affinity Nerve Growth Factor Receptor Price Trend (2014-2019)
      • 6.2 Japan High Affinity Nerve Growth Factor Receptor Sales Market Share by Company
      • 6.3 Japan High Affinity Nerve Growth Factor Receptor Sales Market Share by Type
      • 6.4 Japan High Affinity Nerve Growth Factor Receptor Sales Market Share by Application

      7 Southeast Asia High Affinity Nerve Growth Factor Receptor Sales, Revenue and Price

      • 7.1 Southeast Asia High Affinity Nerve Growth Factor Receptor Sales and Value (2014-2019)
        • 7.1.1 Southeast Asia High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2014-2019)
        • 7.1.2 Southeast Asia High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2014-2019)
        • 7.1.3 Southeast Asia High Affinity Nerve Growth Factor Receptor Price Trend (2014-2019)
      • 7.2 Southeast Asia High Affinity Nerve Growth Factor Receptor Sales Market Share by Company
      • 7.3 Southeast Asia High Affinity Nerve Growth Factor Receptor Sales Market Share by Type
      • 7.4 Southeast Asia High Affinity Nerve Growth Factor Receptor Sales Market Share by Application

      8 India High Affinity Nerve Growth Factor Receptor Sales, Revenue and Price

      • 8.1 India High Affinity Nerve Growth Factor Receptor Sales and Value (2014-2019)
        • 8.1.1 India High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2014-2019)
        • 8.1.2 India High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2014-2019)
        • 8.1.3 India High Affinity Nerve Growth Factor Receptor Price Trend (2014-2019)
      • 8.2 India High Affinity Nerve Growth Factor Receptor Sales Market Share by Company
      • 8.3 India High Affinity Nerve Growth Factor Receptor Sales Market Share by Type
      • 8.4 India High Affinity Nerve Growth Factor Receptor Sales Market Share by Application

      9 Company Profiles and Key Figures in High Affinity Nerve Growth Factor Receptor Business

      • 9.1 Array BioPharma Inc
        • 9.1.1 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.1.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.1.4 Main Business and Markets Served
      • 9.2 Astellas Pharma Inc
        • 9.2.1 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.2.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.2.4 Main Business and Markets Served
      • 9.3 AstraZeneca Plc
        • 9.3.1 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.3.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.3.4 Main Business and Markets Served
      • 9.4 Daiichi Sankyo Co Ltd
        • 9.4.1 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.4.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.4.4 Main Business and Markets Served
      • 9.5 Dompe Farmaceutici SpA
        • 9.5.1 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.5.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.5.4 Main Business and Markets Served
      • 9.6 Genzyme Corp
        • 9.6.1 Genzyme Corp High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.6.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.6.4 Main Business and Markets Served
      • 9.7 Handok Inc
        • 9.7.1 Handok Inc Production Sites and Area Served
        • 9.7.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.7.4 Main Business and Markets Served
      • 9.8 Ignyta Inc
        • 9.8.1 Ignyta Inc High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.8.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.8.4 Main Business and Markets Served
      • 9.9 Loxo Oncology Inc
        • 9.9.1 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.9.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.9.4 Main Business and Markets Served
      • 9.10 Merck & Co Inc
        • 9.10.1 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Production Sites and Area Served
        • 9.10.2 High Affinity Nerve Growth Factor Receptor Specification and Application
        • 9.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.10.4 Main Business and Markets Served
      • 9.11 Nerviano Medical Sciences Srl
      • 9.12 Plexxikon Inc
      • 9.13 Proximagen Ltd
      • 9.14 Rottapharm Biotech Srl
      • 9.15 Sienna Biopharmaceuticals Inc
      • 9.16 Tiziana Life Sciences Plc

      10 High Affinity Nerve Growth Factor Receptor Maufacturing Cost Analysis

      • 10.1 High Affinity Nerve Growth Factor Receptor Key Raw Materials Analysis
        • 10.1.1 Key Raw Materials
        • 10.1.2 Key Raw Materials Price Trend
        • 10.1.3 Key Suppliers of Raw Materials
      • 10.2 Proportion of Manufacturing Cost Structure
      • 10.3 Manufacturing Process Analysis of High Affinity Nerve Growth Factor Receptor
      • 10.4 High Affinity Nerve Growth Factor Receptor Industrial Chain Analysis

      11 Marketing Channel, Distributors and Customers

      • 11.1 Marketing Channel
        • 11.1.1 Direct Marketing
        • 11.1.2 Indirect Marketing
      • 11.2 High Affinity Nerve Growth Factor Receptor Distributors List
      • 11.3 High Affinity Nerve Growth Factor Receptor Customers

      12 Market Dynamics

      • 12.1 Market Trends
      • 12.2 Opportunities
      • 12.3 Market Drivers
      • 12.4 Challenges
      • 12.5 Influence Factors

      13 High Affinity Nerve Growth Factor Receptor Market Forecast

      • 13.1 Global High Affinity Nerve Growth Factor Receptor Sales, Revenue and Price Forecast
        • 13.1.1 Global High Affinity Nerve Growth Factor Receptor Sales Growth Forecast (2019-2025)
        • 13.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue Growth Forecast (2019-2025)
        • 13.1.3 Global High Affinity Nerve Growth Factor Receptor Price Trend Forecast (2019-2025)
      • 13.2 Global High Affinity Nerve Growth Factor Receptor Forecast by Region
        • 13.2.1 Global High Affinity Nerve Growth Factor Receptor Sales Growth Forecast by Region (2019-2025)
        • 13.2.2 Global High Affinity Nerve Growth Factor Receptor Revenue Growth Forecast by Region (2019-2025)
        • 13.2.3 United States High Affinity Nerve Growth Factor Receptor Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.4 Europe High Affinity Nerve Growth Factor Receptor Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.5 China High Affinity Nerve Growth Factor Receptor Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.6 Japan High Affinity Nerve Growth Factor Receptor Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.7 Southeast Asia High Affinity Nerve Growth Factor Receptor Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.8 India High Affinity Nerve Growth Factor Receptor Sales, Revenue Growth Forecast (2019-2025)
      • 13.3 Global High Affinity Nerve Growth Factor Receptor Forecast by Type
        • 13.3.1 Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Type (2019-2025)
        • 13.3.2 Global High Affinity Nerve Growth Factor Receptor Revenue Forecast by Type (2019-2025)
        • 13.3.3 Global High Affinity Nerve Growth Factor Receptor Price Forecast by Type (2019-2025)
      • 13.4 Global High Affinity Nerve Growth Factor Receptor Forecast by Application

      14 Research Findings and Conclusion

        15 Methodology and Data Source

        • 15.1 Methodology/Research Approach
          • 15.1.1 Research Programs/Design
          • 15.1.2 Market Size Estimation
          • 15.1.3 Market Breakdown and Data Triangulation
        • 15.2 Data Source
          • 15.2.1 Secondary Sources
          • 15.2.2 Primary Sources
        • 15.3 Author List

        The global High Affinity Nerve Growth Factor Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report studies the global High Affinity Nerve Growth Factor Receptor market status and forecast, categorizes the global High Affinity Nerve Growth Factor Receptor market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

        Major manufacturers covered in this report
        Array BioPharma Inc
        Astellas Pharma Inc
        AstraZeneca Plc
        Daiichi Sankyo Co Ltd
        Dompe Farmaceutici SpA
        Genzyme Corp
        Handok Inc
        Ignyta Inc
        Loxo Oncology Inc
        Merck & Co Inc
        Nerviano Medical Sciences Srl
        Plexxikon Inc
        Proximagen Ltd
        Rottapharm Biotech Srl
        Sienna Biopharmaceuticals Inc
        Tiziana Life Sciences Plc

        In view of regional level, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        ASP-7962
        AZD-7451
        BNN-27
        Cenegermin
        CRB-0089
        Others

        Segment by Application
        Bile Duct Cancer
        Papillary Thyroid Cancer
        Low Back Pain
        Lung Cancer
        Others

        Buy now